Driving Healthcare Innovation in Asia Through Long-Term, Collaborative Giving
The Li Ka Shing Foundation and Temasek Trust are jointly committing S$12 million to a histotripsy clinical trial and cancer research in Singapore, via a Donor-Advised Fund managed by TT Foundation Advisors.